Skip to main content

Table 3 Laboratory values in 44 HD patients on the final day of investigation (Week 5, Day 2; see Table 2); however, values for inflammatory markers, hsCRP, orosomucoid and PTX3, are shown as median values over 4 weeks plus the final day of investigation

From: Inflammation down-regulates CYP3A4-catalysed drug metabolism in hemodialysis patients

Laboratory parameters
 hsCRP, mg/L ª 4.5 (1.5–14.0)
 Interleukin-6, pg/ml 6.0 (3.0–10.6)
 Orosomucoid, g/L ª 1.0 (0.8–1.3)
 Pentraxin 3, ng/ml ª 1.3 (1.1–2.0)
 NT-pro-brain natriuretic peptide, ng/L 6330 (1285–21,830)
 Parathyroid hormone, ng/L 322 (151–587)
 Albumin, g/L 33 (32–36)
 Iron, μg/L 10 (8–13)
 4β-OH-Cholesterol, ng/ml 26 (14–26)
 Cholesterol, mmol/L 3.9 (3.4–4.7)
 Urea reduction rate, % 74 (70–78)
 Hemoglobin, g/L 115 (106–121)
  1. Data presented as median and interquartile range (IQR). ª Median values for high sensitive (hs) CRP, orosomucoid and pentraxin-3 are calculated from the five samples taken during 4 weeks prior to the study plus the last day of the study. The rest of the parameters are sampled at day 2 of week 5